| dc.creator |
Demirdaş, A |
|
| dc.creator |
Kiliç, Faruk |
|
| dc.creator |
Işik, Ümit |
|
| dc.creator |
Usta, A |
|
| dc.date |
2021-05-01T00:00:00Z |
|
| dc.identifier |
fa7a592c-0b80-47b4-8d35-c219bbd56f60 |
|
| dc.identifier |
10.1590/1516-4446-2020-0950 |
|
| dc.identifier |
https://avesis.sdu.edu.tr/publication/details/fa7a592c-0b80-47b4-8d35-c219bbd56f60/oai |
|
| dc.description |
Objective: The purpose of this study was to assess serum Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) concentrations to determine whether changes in patients with schizophrenia could have etiopathogenetic importance. Since very little research has addressed the connection between the inflammatory marker TWEAK and schizophrenia, we wanted to examine alterations of TWEAK and investigate the possible correlation between clinical symptomatology and serum concentrations. |
|
| dc.language |
eng |
|
| dc.rights |
info:eu-repo/semantics/openAccess |
|
| dc.title |
Serum tumor necrosis factor-like weak inducer of apoptosis levels are elevated in schizophrenia. |
|
| dc.type |
info:eu-repo/semantics/article |
|